FDA/Center for Drug Evaluation and Research (CDER) to Genentech, Inc. - Letter

This Other document was issued by the Food and Drug Administration (FDA)

For related information, Open Docket Folder


Content

...Proposal to Withdraw Marketing Approval; Notice of Oppotunity for A Hearing

Attachments

 (1)

FDA/Center for Drug Evaluation and Research (CDER) to Genentech, Inc. - Letter

View Attachment:
Abstract: ...Proposal to Withdraw Marketing Approval; Notice of Oppotunity for A Hearing
Authors: cder
 

 
 
Comment Period Closed
ID: FDA-2010-N-0621-0001

Document Information

Date Posted: Dec 16, 2010
Show More Details  

Comments

416
Comments Received*
FDA, Please hold a public hearing to allow patients, along with their medical oncologists, to assist the drug company in making their case regarding Avastin...
Help me understand the logic in putting the fox in charge of the hen house and expect an impartial hearing as requested by Genentech. You were wise in...

Docket Information

This document is contained in
Related Comments:

* This count refers to the total comment/submissions received on this document, as of 11:59 PM yesterday. Note: Agencies review all submissions, however some agencies may choose to redact, or withhold, certain submissions (or portions thereof) such as those containing private or proprietary information, inappropriate language, or duplicate/near duplicate examples of a mass-mail campaign. This can result in discrepancies between this count and those displayed when conducting searches on the Public Submission document type. For specific information about an agency’s public submission policy, refer to its website or the Federal Register document.